Zobrazeno 1 - 10
of 126
pro vyhledávání: '"D. Helbling"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Immunotherapy. 42:274-277
Mixed adenoneuroendocrine carcinoma (MANEC) is a rare, aggressive tumor arising from different localizations along the gastrointestinal tract with generally poor prognosis. We present the case of a 51-year-old female patient with histopathologically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::296d2826ae4b8e5c9ea70d8566ea8515
https://doi.org/10.1097/cji.0000000000000279
https://doi.org/10.1097/cji.0000000000000279
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
D Helbling, F Stenner, C Rothermundt, C Rentsch, O Shahin, HH Seifert, K Zaugg, A Lorch, F Mayer, J Beyer, S Gillessen, Santis De
Publikováno v:
Swiss Medical Weekly, Vol 140, Iss 2526 (2010)
Externí odkaz:
https://doaj.org/article/e466be68876a4164be9e866776a29b3e
Autor:
Jan Schmidt, Anwar Giryes, Arianeb Mehrabi, Othmar Schöb, Hazem Elhadedy, D. Helbling, Ulf Petrausch, Hani Oweira, Omar Abdel-Rahman
Publikováno v:
Expert Review of Gastroenterology & Hepatology. 11:865-869
Population-based data on the development of second malignant neoplasms (SMNs) following the diagnosis of hepatocellular carcinoma (HCC) are uncommon. We evaluated this clinical vignette in HCC patients within the Surveillance, Epidemiology and End Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2859011bb612c9b5bc7b7d659ce68e6
https://doi.org/10.1080/17474124.2017.1355235
https://doi.org/10.1080/17474124.2017.1355235
Autor:
D. Helbling, Jan Schmidt, Mostafa Eltobgy, Omar Abdel-Rahman, Hani Oweira, Ulf Petrausch, Arianeb Mehrabi, Othmar Schöb, Anwar Giryes, Michael Decker
Publikováno v:
Expert Review of Neurotherapeutics. 17:725-736
Immune-related neurologic toxicities are uncommon but serious adverse events that may be associated with the use of immune checkpoint inhibitors. The objective of this review is to assess the incidence and risk of neurologic toxicities which are pote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd5023708ced0620bf938bb277497524
https://doi.org/10.1080/14737175.2017.1336088
https://doi.org/10.1080/14737175.2017.1336088
Autor:
Omar Abdel-Rahman, Ulf Petrausch, Hani Oweira, D. Helbling, Anwar Giryes, Meinrad Mannhart, A. Mehrabi, Jan Schmidt, Othmar Schöb
Publikováno v:
Clinical Oncology. 29:218-230
Aims We carried out a meta-analysis to determine the risk of treatment-related death associated with immune checkpoint inhibitor use in cancer patients. Materials and methods We examined data from the Medline and Google Scholar databases. We also exa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21ce5790bd8ff4b0a34391e82a92d982
https://doi.org/10.1016/j.clon.2016.11.007
https://doi.org/10.1016/j.clon.2016.11.007
Autor:
Anwar Giryes, Jan Schmidt, Michael Decker, Hani Oweira, Sarah El-Nakeep, Noha Rashad, Arianeb Mehrabi, Ulf Petrausch, D. Helbling, Omar Abdel-Rahman
Publikováno v:
Expert Review of Gastroenterology & Hepatology. :1-10
We aimed to assess the efficacy and safety of delivering intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases. Areas covered: A comprehensive literature search
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::284508367ed38785187a44c21f0207f3
https://doi.org/10.1080/17474124.2017.1284586
https://doi.org/10.1080/17474124.2017.1284586
Autor:
Juerg Bernhard, Daniela Baertschi, Roger von Moos, Piercarlo Saletti, Alessandro Lugli, Christiane Andrieu, Luca Quagliata, Dieter Koeberle, Daniel Dietrich, Andreas Wicki, Sara Bastian, D. Helbling, Marc Kueng, Ralph Winterhalder, Dirk L. Kienle, Karin Ribi, Daniel Horber
Introduction While the anti-VEGF antibody bevacizumab was studied repeatedly as part of low-intensity regimens in less fit elderly patients with metastatic colorectal cancer (mCRC), anti-EGFR antibodies as upfront treatment modality have been scarcel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e9435fde366a1de8ee992d3c70cb594
